Docusign (DOCU)
NASDAQInformation TechnologySoftware - ApplicationSnapshot 2026-07-31
Reading DOCU? Create a free portfolio, then add this holding for ongoing Reports and tracking. Track it in a free portfolio. No credit card.
Create your account →NASDAQInformation TechnologySoftware - ApplicationSnapshot 2026-07-31
Reading DOCU? Create a free portfolio, then add this holding for ongoing Reports and tracking. Track it in a free portfolio. No credit card.
Create your account →Daily closes. Earnings/event dots are placed inline.
Industries move in repeating boom-and-bust cycles. This shows where this stock’s industry sits in that cycle, stage by stage (recovery → expansion → supercycle → steady → deceleration → contraction), from its fundamentals (orders, revenue, capital spending), not the stock’s price.
A booming industry is a tailwind for the names in it; a contracting one is a headwind. Companies in the same industry tend to rise and fall together with the cycle, the way a tide lifts and lowers every boat in the harbor at once, so a large part of a stock’s swing can come from where its industry sits rather than from the company itself. It’s context for reading the company’s results, not a buy/sell call. Full explanation →
Application Software is in steady. Describes the industry's cycle state, not a call on this stock.
The stage band shows the industry’s cycle over the chart’s timeline (each color a stage); a ▼ marks a quarter its growth inflected down — amber is an unconfirmed watch, red is confirmed the next quarter. Use “Overlay cycle on chart” to tint the price chart by stage. The industry’s fundamentals, not a signal on this stock.
The reason to own it still holds.
View ThesisRevenue is growing steadily — about 8% over the past year.
View GrowthRanks among the strongest in its industry on quality — around the top 8%.
View QualityManagement screens strong on capital allocation, earnings delivery, margins, the balance sheet, market reaction to earnings.
View ManagementExpectations look reasonable — what the market is pricing in sits in line with or below what analysts forecast.
View ValuationThis stock is volatile — it swings about 2% on a typical day and fell roughly 51% in its worst 12-month stretch.
View RiskDocuSign's growth in expanding its AI-native IAM platform is essential to justify its current valuation. Revenue grew 9% year over year, and the latest earnings report showed a positive surprise of 10.1%. It trades at 13× P/E versus a peer median of 25×, indicating that the price reflects less growth than forecasted. A specific risk is the 20% probability of a miss in the next quarter, which could negatively impact investor sentiment. Peer multiples imply a price about 47% above where it trades. Our read remains intact.
Trailing returns as of 2026-07-31. DOCU is total return (includes dividends); the S&P 500 benchmark is price return (the index excludes dividends).
Based on 22 analysts currently covering DOCU (as of Jul 2026).
Based on 3 Wall Street analysts offering 12-month price targets for DOCU in the last 4 months.
A consensus fair price across 11 valuation methods, at three horizons. As of 2026-08-01. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
A price-focused, side-by-side fair-value read versus Application Software — fair value, gap to price, and forward P/E.
Our valuation methods disagree too much on this name right now. Rather than print a number we don't believe, we're holding it back until they converge.
Advances: Expand AI-native IAM platform
Advances AI-native IAM platform, aligning with management's objectives.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
End-of-day figures as of 2026-07-31. EPS is implied from price ÷ P/E. Not investment advice.
Current $54.83
The last 12 months of price, then the range of analyst 12-month targets from today’s $54.83.
Analyst ratings and price targets are third-party Wall Street estimates, not QuarterlyIQ’s view. Not investment advice.
A long-thesis check that carries the widest uncertainty of the three horizons.
Top 10% on quality vs scored peers
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
Advances: Enhance free cash flow
Efficiency moves enhance profitability and free cash flow.
Analyst upgrade supports revenue growth expectations.
Strong revenue growth and buybacks align with growth objectives.
Beating expectations indicates strong growth trajectory.
Advances: Expand AI-native IAM platform
Launch of IAM platform aligns with AI-native expansion objective.
Acquisition of Lexion supports growth and product expansion.
